Skip to main content

MEDIFAST INC Value Stock - Dividend - Research Selection

Medifast inc

ISIN: US58470H1014 , WKN: 889384

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is based in Baltimore, Maryland.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Earnings Release: Here's Why Analysts Cut Their Medifast, Inc. (NYSE:MED) Price Target To US$15.00

2025-05-02
Investors in Medifast, Inc. ( NYSE:MED ) had a good week, as its shares rose 6.7% to close at US$12.98 following the...

Medifast First Quarter 2025 Earnings: EPS Beats Expectations

2025-05-01
Medifast ( NYSE:MED ) First Quarter 2025 Results Key Financial Results Revenue: US$115.7m (down 34% from 1Q 2024). Net...

Estée Lauder (EL) To Report Earnings Tomorrow: Here Is What To Expect

2025-04-30
Beauty products company Estée Lauder (NYSE:EL) will be reporting earnings tomorrow before market hours. Here’s what to look for.

Medifast Q1 Loss Wider Than Expected, Sales Down 33.8% Y/Y

2025-04-29
MED's first-quarter results show challenges from fewer active OPTAVIA Coaches. Nonetheless, the company is focusing on revitalizing its coach base for growth.

Q1 2025 Medifast Inc Earnings Call

2025-04-29
Q1 2025 Medifast Inc Earnings Call

Medifast Inc (MED) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Focus

2025-04-29
Despite a significant revenue drop, Medifast Inc (MED) emphasizes coach empowerment and maintains a strong cash position.

Medifast (NYSE:MED) Misses Q1 Sales Targets

2025-04-28
Wellness company Medifast (NYSE:MED) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 33.8% year on year to $115.7 million. Next quarter’s revenue guidance of $95 million underwhelmed, coming in 15.4% below analysts’ estimates. Its GAAP loss of $0.07 per share was 72% above analysts’ consensus estimates.

Medifast: Q1 Earnings Snapshot

2025-04-28
BALTIMORE (AP) — Medifast Inc. MED) on Monday reported a loss of $772,000 in its first quarter. On a per-share basis, the Baltimore-based company said it had a loss of 7 cents.

Medifast Announces First Quarter 2025 Financial Results

2025-04-28
BALTIMORE, April 28, 2025--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ended March 31, 2025.

Medifast, Inc. (MED) Q1 2025 Earnings Call Transcript

2025-04-28
Medifast, Inc. (NYSE:MED) Q1 2025 Earnings Conference Call April 28, 2025 4:30 PM ETCompany ParticipantsSteven Zenker - Vice President, Investor...